Top Markets
#1 GoPlus Security GoPlus Security +31.51%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.70%
#3 Status Status +17.55%
#4 Wrapped NXM Wrapped NXM +14.47%
#5 BankrCoin BankrCoin +11.13%
#6 Pons Pons +10.73%
#7 Bedrock Bedrock +10.01%
#8 Ontology Gas Ontology Gas +9.25%
#9 DMT-NAT DMT-NAT +8.78%
#10 o1.exchange o1.exchange +7.41%
Coin of the day
GoPlus Security GoPlus Security
Settings
Language
ENGLISH
Currency
USD
Theme
PJSC Pharmsynthez PJSC Pharmsynthez

PJSC Pharmsynthez

LIFE
Rank in Stocks #34084
PJSC Pharmsynthez, a pharmaceutical enterprise, focuses on the investigation,... PJSC Pharmsynthez, a pharmaceutical enterprise, focuses on the investigation, production, and supply of both proprietary (officinal) and generic active pharmaceutical ingredients across Russia and the Commonwealth of Independent States (CIS). Its portfolio of branded medicines includes Neovir, Segidrin, Fenasid, and Penkrofton, which are employed in critical therapeutic areas such as oncology, gynecology, the management of immune deficiencies, and tuberculosis. Public Joint-Stock Company Pharmsynthez has also established a collaboration with HiFiBiO Therapeutics Inks for the clinical advancement and market introduction of their SARS-CoV-2 neutralizing antibody within Russia. The company, which began operations in 1996, is headquartered in St. Petersburg, Russia.
Share Price
$0.02082992
Last synced: 2026-08-14
Market Cap
$6.27M
Change (1 day)
-3.31%
Change (1 year)
-51.62%
Country
RU
Trade PJSC Pharmsynthez (LIFE)

Category

Healthcare
Stock price history for PJSC Pharmsynthez (LIFE)
Highest end of day price: $0.02 on 2026-08-01

Lowest end of day price: $0.76 on 2010-11-01
Stock price history of PJSC Pharmsynthez from 2010 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -9.44%
2025 30.97%
2024 -44.82%
2023 -11.95%
2022 -18.74%
2021 -19.66%
2020 45.23%
2019 -22.41%
2018 -56.43%
2017 -26.82%
2016 72.01%
2015 -33.83%
2014 -51.22%
2013 7.71%
2012 -30.67%
2011 -14.49%
2010 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE